Does EPCORITAMAB-BYSP Cause Cytokine release syndrome? 369 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 369 reports of Cytokine release syndrome have been filed in association with EPCORITAMAB-BYSP. This represents 37.7% of all adverse event reports for EPCORITAMAB-BYSP.
369
Reports of Cytokine release syndrome with EPCORITAMAB-BYSP
37.7%
of all EPCORITAMAB-BYSP reports
136
Deaths
87
Hospitalizations
How Dangerous Is Cytokine release syndrome From EPCORITAMAB-BYSP?
Of the 369 reports, 136 (36.9%) resulted in death, 87 (23.6%) required hospitalization, and 29 (7.9%) were considered life-threatening.
Is Cytokine release syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB-BYSP. However, 369 reports have been filed with the FAERS database.
What Other Side Effects Does EPCORITAMAB-BYSP Cause?
Diffuse large b-cell lymphoma (206)
Diffuse large b-cell lymphoma refractory (198)
Pyrexia (79)
Immune effector cell-associated neurotoxicity syndrome (77)
Covid-19 (39)
Neutrophil count decreased (35)
Hypogammaglobulinaemia (32)
Platelet count decreased (32)
Cytomegalovirus infection (31)
Pneumonia (29)
What Other Drugs Cause Cytokine release syndrome?
AXICABTAGENE CILOLEUCEL (4,140)
CYCLOPHOSPHAMIDE (2,263)
TISAGENLECLEUCEL (1,660)
FLUDARABINE (1,458)
RITUXIMAB (1,404)
BLINATUMOMAB (952)
DEXAMETHASONE (853)
DOXORUBICIN (850)
BREXUCABTAGENE AUTOLEUCEL (827)
VINCRISTINE (771)
Which EPCORITAMAB-BYSP Alternatives Have Lower Cytokine release syndrome Risk?
EPCORITAMAB-BYSP vs EPERISONE
EPCORITAMAB-BYSP vs EPHEDRINE
EPCORITAMAB-BYSP vs EPINASTINE
EPCORITAMAB-BYSP vs EPINEPHRINE
EPCORITAMAB-BYSP vs EPINEPHRINE\LIDOCAINE